Jushi Holdings Inc. Announces Participation at Upcoming Conferences in December 2020

BOCA RATON, Fla., Nov. 20, 2020 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced that Erich Mauff, President, Board Member and Founder of Jushi, will participate at two upcoming conferences:

  • Cowen Inc.’s 3rd Annual Boston Cannabis Conference is being held on November 30 – December 2, 2020. Mr. Mauff will be participating in virtual one-on-one investor meetings on Tuesday, December 1, 2020.
  • 2020 Cantor Fitzgerald Virtual MSO Cannabis Summit is being held on December 15 – 16, 2020. Mr. Mauff is scheduled to participate in a fireside chat on Wednesday, December 16, 2020 at 11:30am ET.

For more information about the conferences or to schedule a one-on-one meeting with Jushi’s management during these events, please contact Jushi’s Investor Relations at Investors@jushico.com.

About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.

Investor Relations Contact:
Michael Perlman
Executive Vice President of Investor Relations and Treasury
561-453-1308
Investors@jushico.com

Media Contact:

Ellen Mellody
MATTIO Communications
570-209-2947
Ellen@Mattio.com

Staff

Recent Posts

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

1 hour ago

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…

1 hour ago